Facebook
Twitter
LinkedIn
Forward
Obesity is a heterogeneous, complex, chronic, and progressive disease. It is essential that clinicians recognize that a patient’s disease response to treatment can vary significantly.
|
The rise in the use of glucagon-like peptide 1 receptor agonists (GLP-1RA) for weight loss has generated significant interest due to their efficacy in reducing body weight.
|
Obesity causes or contributes to over 200 diseases including at least 13 types of cancer. People with obesity are also at an elevated risk of death from cancer.
|
This session will include a focused overview of lipedema, bringing together unique perspectives from an occupational therapist (CLT), patient/advocate, and obesity medicine physician, combining dec
|
Year in Review presentation with outgoing and incoming OMA PresidentCME/CE Expiration Date: 4/27/28
|
The core of obesity treatment are lifestyle factors including physical activity.
|
Review Course for the 2025 ABOM Exam
|
Obesity Medicine 2023 - Spring Obesity Summit
|
|
Pediatric obesity continues to be a critical health issue in the United States, but access to specialized care remains limited, especially outside of urban teaching hospitals.
|